Breaking News Instant updates and real-time market news.

2022-07-07 06:52:59 NEWR New Relic $52.20 / -0.91 (-1.71%) 06:52 07/07/22 07/07 06:52 07/07/22 06:52	New Relic initiated with a Buy at Canaccord Canaccord analyst Kingsley Crane initiated coverage of New Relic with a Buy rating and $81 price target. New Relic is a "newly empowered company with a fresh take on observability," which collects and analyzes data to provide better insight into customers' tech stacks, Crane tells investors in a research note. The analyst says a "stellar product at an attractive value compared to competitors is driving net revenue retention higher." He thinks the shares are "simply too cheap" for a "durable" 20% top-line grower.

2022-07-07 06:52:59

NEWR

New Relic

$52.20 / -0.91 (-1.71%)

06:52

07/07/22

07/07

06:52

07/07/22

06:52

New Relic initiated with a Buy at Canaccord

Canaccord analyst Kingsley Crane initiated coverage of New Relic with a Buy rating and $81 price target. New Relic is a "newly empowered company with a fresh take on observability," which collects and analyzes data to provide better insight into customers' tech stacks, Crane tells investors in a research note. The analyst says a "stellar product at an attractive value compared to competitors is driving net revenue retention higher." He thinks the shares are "simply too cheap" for a "durable" 20% top-line grower.

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Nvidia price target lowered to $210 from $220 at Susquehanna » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 NVDA Nvidia $177.97 / -11.97 (-6.30%) Susquehanna analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 Cathie Wood's ARK Investment bought 360K shares of Nvidia today 08/08/22 Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement 07/20/22 Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia 07/15/22 U.S. video game spending falls 11% y/y in June, says NPD NVDA Nvidia $177.97 / -11.97 (-6.30%) 06:41 Today Mizuho Nvidia price target lowered to $250 from $290 at Mizuho 08/08/22 Summit Insights Nvidia underestimated its exposure to crypto mining, says Summit Insights 08/08/22 Oppenheimer Nvidia price target lowered to $250 from $300 at Oppenheimer 08/08/22 Truist Nvidia price target lowered to $216 from $283 at Truist NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B 05/25/22 Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B 05/25/22 Nvidia reports Q1 EPS $1.36, consensus $1.29 05/25/22 Notable companies reporting after market close NVDA Nvidia $177.97 / -11.97 (-6.30%) 07/28/22 House passes bill giving $52B to U.S. chipmakers, Bloomberg reports 07/28/22 Pelosi's husband sells Nvidia shares as House weighs chip bill, Reuters says 07/27/22 Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says 07/19/22 New bill to provide $52B boost to US semiconductor manufacturing, WSJ reports NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/05/22 Here's What You Missed in Crypto This Week 07/29/22 Here's What You Missed in Crypto This Week 08/24/22 Nvidia - NVDA NVDA Nvidia $177.97 / -11.97 (-6.30%) 07/21/22 NVIDIA call buyer realizes 58% same-day gains 06/21/22 Early notable gainers among liquid option names on June 21st 06/17/22 Notable open interest changes for June 17th 05/27/22 Notable open interest changes for May 27th
Earnings	Avanos sees FY22 adjusted EPS $1.45-$1.65, consensus $1.64 » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 AVNS Avanos $28.58 / -0.2 (-0.69%) Sees FY22 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events AVNS Avanos $28.58 / -0.2 (-0.69%) 07/18/22 Stifel Avanos price target lowered to $28 from $37 at Stifel 02/24/22 KeyBanc Avanos price target lowered to $41 from $47 at KeyBanc AVNS Avanos $28.58 / -0.2 (-0.69%) 07:06 Today Avanos reports Q2 adjusted EPS 41c, consensus 38c 05/04/22 Avanos backs FY22 adjusted EPS view $1.55-$1.75, consensus $1.64 05/04/22 Avanos reports Q1 adjusted EPS 26c, consensus 26c 02/23/22 Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 09:00 Today Avanos - AVNS
Recommendations	Union Pacific named short-term buy idea at Deutsche Bank » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 UNP Union Pacific $227.97 / -0.73 (-0.32%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UNP Union Pacific $227.97 / -0.73 (-0.32%) 08/03/22 North American rail traffic increased 0.6% for the week ending July 30 07/27/22 North American rail traffic fell 1.4% for the week ending July 23 07/27/22 Union Pacific signs $1B plus locomotive modernization deal with Wabtec 07/21/22 Union Pacific backs FY22 CapEx view $3.3B UNP Union Pacific $227.97 / -0.73 (-0.32%) 07/22/22 Deutsche Bank Union Pacific price target lowered to $232 from $260 at Deutsche Bank 07/22/22 Susquehanna Union Pacific price target raised to $240 from $235 at Susquehanna 07/22/22 UBS Union Pacific price target lowered to $236 from $267 at UBS 07/15/22 Stifel Union Pacific price target lowered to $225 from $254 at Stifel UNP Union Pacific $227.97 / -0.73 (-0.32%) 07/21/22 Union Pacific reports Q2 EPS $2.93, consensus $2.86 04/21/22 Union Pacific reports Q1 EPS $2.57, consensus $2.55 04/20/22 Notable companies reporting before tomorrow's open 04/20/22 Notable companies reporting before tomorrow's open UNP Union Pacific $227.97 / -0.73 (-0.32%) 03/19/22 Chevron, Verizon among dividend stocks to choose for retirement, Barron's says UNP Union Pacific $227.97 / -0.73 (-0.32%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 06/07/22 Fly Intel: Pre-market Movers 05/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/30/22 Multi-Modal Field Trip UNP Union Pacific $227.97 / -0.73 (-0.32%) 07/05/22 Union Pacific call volume above normal and directionally bullish 02/18/22 Unusually active option classes on open February 18th
Earnings	Endeavour Silver reports Q2 EPS (7c), consensus 3c » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 EXK Endeavour Silver $3.77 / +0.08 (+2.17%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options EXK Endeavour Silver $3.77 / +0.08 (+2.17%) 07/08/22 Endeavour Silver reports Q2 production 1,359,207 silver oz, 9,289 gold oz 05/11/22 Endeavour Silver rises 16.5% 05/11/22 Endeavour Silver rises 18.4% 04/11/22 Endeavour Silver reports Q1 production of 1,314,955 silver ounces EXK Endeavour Silver $3.77 / +0.08 (+2.17%) 05/27/22 Stifel Endeavour Silver price target lowered to C$6.50 from C$7.50 at Stifel 05/12/22 BMO Capital Endeavour Silver price target lowered to C$5.25 from C$6 at BMO Capital 05/12/22 TD Securities Endeavour Silver price target lowered to C$5.50 from C$7 at TD Securities 04/12/22 BMO Capital Endeavour Silver price target raised to C$6 from C$5.75 at BMO Capital EXK Endeavour Silver $3.77 / +0.08 (+2.17%) 05/11/22 Endeavour Silver reports Q1 EPS 7c, consensus 5c 16 Mar EXK Endeavour Silver $3.77 / +0.08 (+2.17%) 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning 13:00 Today Endeavour Silver - EXK EXK Endeavour Silver $3.77 / +0.08 (+2.17%) 05/02/22 Largest borrow rate increases among liquid names
Hot Stocks	Cognition Therapeutics expects cash to fund operations into Q4 of 2023 » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) Cash and cash equivalents… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 07/19/22 Cognition Therapeutics to present analyses from ongoing trial of CT1812 06/23/22 Cognition Therapeutics doses first patient in study of CT1812 05/11/22 Cognition Therapeutics sees cash, equivalents funding operations into 2H23 05/03/22 Cognition presents preclinical findings on sigma-2 receptor modulators CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 04/22/22 Ladenburg Cognition Therapeutics initiated with a Buy at Ladenburg 01/24/22 B. Riley Cognition Therapeutics price target lowered to $20 from $27 at B. Riley 11/03/21 Fly Intel: Top five analyst initiations 11/03/21 B. Riley Cognition Therapeutics initiated with a Buy at B. Riley CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 07:06 Today Cognition Therapeutics reports Q2 EPS (25c), consensus (32c) 05/11/22 Cognition Therapeutics reports Q1 EPS (17c), consensus (29c) 03/30/22 Cognition Therapeutics reports 2021 EPS ($3.13) vs ($23.76) last year 08 Oct CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/29/22 7th Annual Healthcare Conference
Hot Stocks	Freeline expects cash to fund operating expenses into 2H23 » 07:07 08/09/22 08/09 07:07 08/09/22 07:07 FRLN Freeline / + Unrestricted cash and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FRLN Freeline / + 07/21/22 Freeline announces NEJM published data on FLT180a 07/10/22 Freeline presents data from first cohort of Phase 1/2 dose-confirmation B-LIEVE 06/24/22 Freeline to present new clinical data for FLT180a at ISTH 06/14/22 Freeline imitates dosing of second cohort in B-LIEVE dose confirmation trial FRLN Freeline / + 06/13/22 Wedbush Sangamo assumed with a Neutral, $5 price target at Wedbush 02/01/22 Morgan Stanley Morgan Stanley downgrades Freeline ahead of 'year of pipeline execution' 02/01/22 Morgan Stanley Freeline downgraded to Equal Weight from Overweight at Morgan Stanley 01/07/22 Redburn Freeline upgraded to Buy from Neutral at Redburn FRLN Freeline / + 07:06 Today Freeline reports 1H EPS (95c) vs. ($2.10) last year 05/10/22 Freeline reports Q1 EPS (63c) consensus (68c) 00:00 Today Wedbush PacGrow Healthcare Virtual Conference
Earnings	Cognition Therapeutics reports Q2 EPS (25c), consensus (32c) » 07:06 08/09/22 08/09 07:06 08/09/22 07:06 CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) "The second quarter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 07/19/22 Cognition Therapeutics to present analyses from ongoing trial of CT1812 06/23/22 Cognition Therapeutics doses first patient in study of CT1812 05/11/22 Cognition Therapeutics sees cash, equivalents funding operations into 2H23 05/03/22 Cognition presents preclinical findings on sigma-2 receptor modulators CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 04/22/22 Ladenburg Cognition Therapeutics initiated with a Buy at Ladenburg 01/24/22 B. Riley Cognition Therapeutics price target lowered to $20 from $27 at B. Riley 11/03/21 Fly Intel: Top five analyst initiations 11/03/21 B. Riley Cognition Therapeutics initiated with a Buy at B. Riley CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 05/11/22 Cognition Therapeutics reports Q1 EPS (17c), consensus (29c) 03/30/22 Cognition Therapeutics reports 2021 EPS ($3.13) vs ($23.76) last year 08 Oct CGTX Cognition Therapeutics $2.77 / -0.33 (-10.65%) 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/29/22 7th Annual Healthcare Conference
Earnings	Freeline reports 1H EPS (95c) vs. ($2.10) last year » 07:06 08/09/22 08/09 07:06 08/09/22 07:06 FRLN Freeline / + "In the second… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FRLN Freeline / + 07/21/22 Freeline announces NEJM published data on FLT180a 07/10/22 Freeline presents data from first cohort of Phase 1/2 dose-confirmation B-LIEVE 06/24/22 Freeline to present new clinical data for FLT180a at ISTH 06/14/22 Freeline imitates dosing of second cohort in B-LIEVE dose confirmation trial FRLN Freeline / + 06/13/22 Wedbush Sangamo assumed with a Neutral, $5 price target at Wedbush 02/01/22 Morgan Stanley Morgan Stanley downgrades Freeline ahead of 'year of pipeline execution' 02/01/22 Morgan Stanley Freeline downgraded to Equal Weight from Overweight at Morgan Stanley 01/07/22 Redburn Freeline upgraded to Buy from Neutral at Redburn FRLN Freeline / + 05/10/22 Freeline reports Q1 EPS (63c) consensus (68c) 00:00 Today Wedbush PacGrow Healthcare Virtual Conference
Earnings	Avanos reports Q2 adjusted EPS 41c, consensus 38c » 07:06 08/09/22 08/09 07:06 08/09/22 07:06 AVNS Avanos $28.58 / -0.2 (-0.69%) Reports Q2 revenue $203M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events AVNS Avanos $28.58 / -0.2 (-0.69%) 07/18/22 Stifel Avanos price target lowered to $28 from $37 at Stifel 02/24/22 KeyBanc Avanos price target lowered to $41 from $47 at KeyBanc AVNS Avanos $28.58 / -0.2 (-0.69%) 05/04/22 Avanos backs FY22 adjusted EPS view $1.55-$1.75, consensus $1.64 05/04/22 Avanos reports Q1 adjusted EPS 26c, consensus 26c 02/23/22 Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 02/23/22 Avanos reports Q4 adjusted EPS 46c, consensus 40c 09:00 Today Avanos - AVNS
Earnings	Advent Technologies reports Q2 EPS (22c) vs. (7c) last year » 07:05 08/09/22 08/09 07:05 08/09/22 07:05 ADN Advent Technologies $2.98 / +0.06 (+2.05%) Reports Q2 revenue $2.4M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ADN Advent Technologies $2.98 / +0.06 (+2.05%) 08/08/22 Advent Technologies and DEPA Commercial, sign MoU for hydrogen projects 07/18/22 Advent receives official ratification from EU for 'Green HiPo' IPCEI Project 06/16/22 Advent announces notification of EUR 782.1M project funding from Greek State 05/09/22 Advent Technologies announces technology assessment agreement ADN Advent Technologies $2.98 / +0.06 (+2.05%) 06/16/22 Jefferies Advent Technologies price target lowered to $4 from $11.20 at Jefferies ADN Advent Technologies $2.98 / +0.06 (+2.05%) 05/12/22 Advent Technologies reports Q1 EPS (8c) vs 7c in last year's quarter 09:00 Today Advent Technologies - ADN ADN Advent Technologies $2.98 / +0.06 (+2.05%) 07/14/22 Largest borrow rate increases among liquid names 07/05/22 Largest borrow rate increases among liquid names 04/06/22 Unusually active option classes on open April 6th

Initiation	Rigetti Computing initiated with a Buy at Deutsche Bank » 07:05 08/09/22 08/09 07:05 08/09/22 07:05 RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) 08/04/22 Rigetti Computing awarded DARPA contract for Quantum Application Benchmarking 07/06/22 Rigetti Computing announces chairperson transition 06/27/22 Rigetti Computing to join Russell 3000 Index 06/21/22 Rigetti Computing launches Aspen-series quantum computer in the UK RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) 06/10/22 Benchmark Rigetti Computing price target lowered to $12 from $16 at Benchmark 06/08/22 Needham Needham starts Rigetti Computing at Buy citing its vertically-integrated model 06/07/22 Needham Rigetti Computing initiated with a Buy at Needham 05/27/22 Cowen Rigetti Computing initiated with an Outperform at Cowen RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) 03/10/22 Rigetti Computing reports 2021 EPS ($1.74) vs. ($1.26) last year RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) 05/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/27/22 Week in SPAC News: Trump SPAC in spotlight as Truth Social makes users wait 08/11/22 Rigetti Computing - RGTI RGTI Rigetti Computing $4.55 / +0.1 (+2.25%) 03/02/22 new option listings and two option delistings on March 2nd
Hot Stocks	Immatics expects cash to fund operations into 2H of 2024 » 07:05 08/09/22 08/09 07:05 08/09/22 07:05 IMTX Immatics $12.90 / +0.47 (+3.78%) Cash and cash equivalents… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IMTX Immatics $12.90 / +0.47 (+3.78%) 06/07/22 Immatics, Editas Medicine announce strategic collaboration and licensing pact 06/02/22 Immatics sees cash runway into 2H24 06/02/22 Immatics, Bristol-Myers expand alliance to pursue TCR-T and/or CAR-T programs 05/18/22 Immatics announces first patient treated with IMA203, nivolumab combination IMTX Immatics $12.90 / +0.47 (+3.78%) 12/14/21 SVB Leerink SVB Leerink positive on Bristol-Myers deal, ups Immatics price target to $32 12/14/21 SVB Leerink Immatics price target raised to $32 from $28 at SVB Leerink IMTX Immatics $12.90 / +0.47 (+3.78%) 07:05 Today Immatics reports Q2 EPS (EUR 0.22) vs (EUR 0.42) last year 06/02/22 Immatics reports Q1 EPS EUR 1.35 vs. (EUR0.36) last year 03/23/22 Immatics reports 2021 EPS (EUR 1.48) vs (EUR 4.40) last year
Recommendations	Epam Systems price target raised to $496 from $370 at Susquehanna » 07:05 08/09/22 08/09 07:05 08/09/22 07:05 EPAM Epam Systems $427.63 / +0.62 (+0.15%) Susquehanna analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EPAM Epam Systems $427.63 / +0.62 (+0.15%) 05/05/22 Epam Systems rises 11.8% 05/05/22 Epam Systems rises 8.8% 04/08/22 Epam Systems rises 12.9% 03/29/22 Epam Systems rises 15.7% EPAM Epam Systems $427.63 / +0.62 (+0.15%) 08/08/22 Barclays Epam Systems price target raised to $485 from $410 at Barclays 08/05/22 Cowen Epam Systems price target raised to $440 from $400 at Cowen 08/04/22 Stifel Epam Systems price target raised to $500 from $411 at Stifel 07/18/22 Piper Sandler Epam Systems price target lowered to $381 from $403 at Piper Sandler EPAM Epam Systems $427.63 / +0.62 (+0.15%) 08/04/22 Epam Systems sees Q3 adjusted EPS $2.48, consensus $1.99 08/04/22 Epam Systems reports Q2 EPS $2.38, consensus $1.72 05/05/22 Epam Systems sees Q2 EPS at least $1.70, consensus $1.71 05/05/22 Epam Systems reports Q1 EPS $2.49, consensus $1.77 EPAM Epam Systems $427.63 / +0.62 (+0.15%) 02/28/22 What You Missed On Wall Street On Monday 08/30/22 Mexico Tech Services Field Trip EPAM Epam Systems $427.63 / +0.62 (+0.15%) 08/04/22 Early notable gainers among liquid option names on August 4th 05/05/22 Early notable gainers among liquid option names on May 5th 05/02/22 Early notable gainers among liquid option names on May 2nd 04/08/22 Early notable gainers among liquid option names on April 8th
Earnings	Immatics reports Q2 EPS (EUR 0.22) vs (EUR 0.42) last year » 07:05 08/09/22 08/09 07:05 08/09/22 07:05 IMTX Immatics $12.90 / +0.47 (+3.78%) Reports Q2 revenue EUR… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IMTX Immatics $12.90 / +0.47 (+3.78%) 06/07/22 Immatics, Editas Medicine announce strategic collaboration and licensing pact 06/02/22 Immatics sees cash runway into 2H24 06/02/22 Immatics, Bristol-Myers expand alliance to pursue TCR-T and/or CAR-T programs 05/18/22 Immatics announces first patient treated with IMA203, nivolumab combination IMTX Immatics $12.90 / +0.47 (+3.78%) 12/14/21 SVB Leerink SVB Leerink positive on Bristol-Myers deal, ups Immatics price target to $32 12/14/21 SVB Leerink Immatics price target raised to $32 from $28 at SVB Leerink IMTX Immatics $12.90 / +0.47 (+3.78%) 06/02/22 Immatics reports Q1 EPS EUR 1.35 vs. (EUR0.36) last year 03/23/22 Immatics reports 2021 EPS (EUR 1.48) vs (EUR 4.40) last year
Periodicals	Cathie Wood's funds sold over 1.4M Coinbase shares on July 26, Bloomberg says » 07:04 08/09/22 08/09 07:04 08/09/22 07:04 COIN Coinbase $98.01 / +5.025 (+5.40%) , SHOP Shopify $39.74 / -1.02 (-2.50%) Three of Cathie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 08/04/22 Coinbase trading resumes 08/04/22 Coinbase trading halted, volatility trading pause 08/04/22 Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock 08/04/22 Coinbase selected by BlackRock for crypto trading access SHOP Shopify $39.74 / -1.02 (-2.50%) 08/02/22 Shopify and Klaviyo announce strategic partnership 07/27/22 Shopify sees GMV growth outperforming broader retail market in 2H 07/27/22 Shopify expects to generate adjusted operating loss for 2H 07/27/22 Shopify reports Q2 GMV $46.9B, up 11% over last year COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 08/08/22 Daiwa Coinbase downgraded to Outperform from Buy at Daiwa 08/05/22 Citi Citi cuts Coinbase target but opens 'upside Catalyst Watch' 08/04/22 JMP Securities JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin 08/04/22 Mizuho Coinbase shares jumped 20% 'for no good reason,' says Mizuho SHOP Shopify $39.74 / -1.02 (-2.50%) 08/05/22 KGI Securities Shopify downgraded to Neutral from Outperform at KGI Securities 07/28/22 RBC Capital Shopify price target lowered to $60 from $70 at RBC Capital 07/28/22 Canaccord Shopify price target lowered to $40 from $45 at Canaccord 07/28/22 Deutsche Bank Shopify price target lowered to $40 from $50 at Deutsche Bank COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 05/10/22 Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year 05/10/22 Coinbase reports Q1 revenue $1.165B, consensus $1.48B 05/10/22 Notable companies reporting after market close 02/24/22 Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y SHOP Shopify $39.74 / -1.02 (-2.50%) 07/27/22 Shopify reports Q2 adjusted EPS (3c), consensus 3c 07/26/22 Notable companies reporting before tomorrow's open 07/26/22 Notable companies reporting before tomorrow's open 05/05/22 Shopify reports Q1 adjusted EPS 20c, consensus 88c COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 08/08/22 Coinbase suffering from this year's crypto collapse, WSJ reports 08/04/22 Coinbase 'shot down many bear cases' with BlackRock pact, Citron says 07/26/22 Coinbase under investigation by SEC on cryptocurrency listing, Bloomberg reports 07/25/22 Coinbase investigated by SEC on cryptocurrency listing, Bloomberg reports SHOP Shopify $39.74 / -1.02 (-2.50%) 07/26/22 Shopify to lay off 10% of employees, or 1,000 workers, WSJ reports 07/06/22 Shopify quietly delays compensation overhaul, Globe and Mail reports 06/22/22 Twitter, Shopify partner to bring products to Twitter Shopping, TechCrunch says 06/07/22 Shopify shareholders approve 10-for-1 stock split, Bloomberg reports COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 08/08/22 What You Missed On Wall Street This Morning 08/05/22 Here's What You Missed in Crypto This Week 08/04/22 What You Missed On Wall Street On Thursday 08/04/22 What You Missed On Wall Street This Morning SHOP Shopify $39.74 / -1.02 (-2.50%) 07/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/27/22 What You Missed On Wall Street On Wednesday 07/27/22 What You Missed On Wall Street This Morning 07/27/22 Fly Intel: Pre-market Movers 08/08/22 42nd Annual Global I Growth Conference 17:30 Today Coinbase - COIN COIN SHOP COIN Coinbase $98.01 / +5.025 (+5.40%) 08/05/22 Notable open interest changes for August 5th 07/27/22 Coinbase put buyer realizes 439% same-day gains 06/22/22 Coinbase put volume heavy and directionally bearish 05/13/22 Unusually active option classes on open May 13th SHOP Shopify $39.74 / -1.02 (-2.50%) 07/28/22 Largest borrow rate increases among liquid names 07/27/22 Unusually active option classes on open July 27th 07/05/22 Unusually active option classes on open July 5th 07/01/22 Unusually active option classes on open July 1st
Hot Stocks	Denison Mines makes further proposal to acquire UEX Corp. for 51c per share » 07:04 08/09/22 08/09 07:04 08/09/22 07:04 DNN Denison Mines $1.24 / +0.08 (+6.93%) , UEXCF UEX Corp. / + , UEC Uranium Energy $4.23 / -0.03 (-0.71%) Denison Mines (DNN) has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DNN UEC DNN Denison Mines $1.24 / +0.08 (+6.93%) 08/08/22 Denison Mines announces expiration of offer to acquire UEX Corporation 08/05/22 Uranium Energy confirms intention to acquire UEX Corporation 08/03/22 Denison Mines announces completion of metallurgical test on Phoenix plant 07/29/22 Denison Mines confirms proposal for UEX Corporation UEC Uranium Energy $4.23 / -0.03 (-0.71%) 08/08/22 Uranium Energy and UEX Corp. announce amendment to arrangement agreement 08/05/22 Uranium Energy confirms intention to acquire UEX Corporation 08/02/22 Uranium Energy submits offer to supply uranium and conversion services to NNSA 07/29/22 Denison Mines confirms proposal for UEX Corporation DNN UEXCF UEC DNN Denison Mines $1.24 / +0.08 (+6.93%) 05/27/22 TD Securities Denison Mines upgraded to Speculative Buy from Hold at TD Securities 01/14/22 TD Securities Denison Mines price target lowered to C$2.25 from C$2.40 at TD Securities 11/15/21 Raymond James Denison Mines price target raised to C$2.60 from C$2.40 at Raymond James 09/23/21 Canaccord Denison Mines price target raised to C$3 from C$2.50 at Canaccord UEXCF UEX Corp. / + 06/13/22 Canaccord Uranium Energy upgraded to Speculative Buy after deal at Canaccord UEC Uranium Energy $4.23 / -0.03 (-0.71%) 06/15/22 Canaccord Uranium Energy price target raised to $6 from $5.50 at Canaccord 06/13/22 Canaccord Uranium Energy upgraded to Speculative Buy after deal at Canaccord 06/13/22 Canaccord Uranium Energy upgraded to Speculative Buy from Hold at Canaccord 04/22/22 Canaccord Uranium Energy downgraded to Hold at Canaccord on valuation DNN DNN Denison Mines $1.24 / +0.08 (+6.93%) 03/03/22 Denison Mines reports Q4 EPS (C$0.01) vs. (C$0.01) a year ago DNN UEC DNN Denison Mines $1.24 / +0.08 (+6.93%) 08/05/22 Largest borrow rate increases among liquid names 08/04/22 Largest borrow rate increases among liquid names 08/01/22 Largest borrow rate increases among liquid names 07/21/22 Largest borrow rate increases among liquid names UEC Uranium Energy $4.23 / -0.03 (-0.71%) 06/14/22 Uranium Energy options imply 6.8% move in share price post-earnings 06/08/22 Uranium Energy options imply 7.1% move in share price post-earnings 06/07/22 Uranium Energy options imply 8.1% move in share price post-earnings 04/13/22 Uranium Energy call volume above normal and directionally bullish
Earnings	Eagle sees FY22 Adjusted non-GAAP R&D expense $46M-$50M vs $32.5M last year » 07:04 08/09/22 08/09 07:04 08/09/22 07:04 EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) Sees FY22 Adjusted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 06/09/22 Eagle Pharmaceuticals complete acquisition of Acacia Pharma 06/01/22 Eagle Pharmaceuticals: AOP Orphan Pharma submits NDA to FDA for landiolol 04/19/22 Eagle announces settlement agreement with Hospira 03/28/22 Eagle Pharmaceuticals to acquire Acacia Pharma for EUR 0.90 per share EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 12/16/21 Barclays Endo price target lowered to $5 from $7 at Barclays 12/15/21 Cantor Fitzgerald Vasopressin approval 'a key win' for Eagle Pharmaceuticals, says Cantor 09/01/21 Piper Sandler Eagle Pharmaceuticals price target raised to $51 from $48 at Piper Sandler 08/31/21 Piper Sandler Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 07:02 Today Eagle Pharmaceuticals reports Q2 non-GAAP EPS $1.78, consensus $3.36 05/09/22 Eagle Pharmaceuticals reports Q1 adjusted EPS $4.10, consensus $3.88 03/07/22 Eagle Pharmaceuticals sees Q1 adjusted EPS $3.80-$4.10, consensus $1.12 03/07/22 Eagle Pharmaceuticals reports Q4 adjusted EPS 85c, consensus 94c EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 03/07/22 What You Missed On Wall Street On Monday 03/07/22 What You Missed On Wall Street This Morning 08:30 Today Eagle Pharmaceuticals - EGRX
Earnings	scPharmaceuticals sees 2022 net loss $43M-$48M » 07:03 08/09/22 08/09 07:03 08/09/22 07:03 SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) Based on its current… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 07/12/22 scPharmaceuticals announces results from AT HOME-HF Phase 2 pilot study 06/30/22 scPharmaceuticals to host FUROSCIX commercial day 06/07/22 scPharmaceuticals announces abstracts accepted for AAHFN meeting 05/16/22 scPharmaceuticals announces FDA acceptance of FUROSCIX NDA SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 08/02/22 Maxim scPharmaceuticals initiated with a Buy at Maxim 09/09/21 SVB Leerink SVB Leerink starts scPharmaceuticals with a Market Perform, $6 target 09/09/21 SVB Leerink scPharmaceuticals initiated with a Market Perform at SVB Leerink SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 07:03 Today scPharmaceuticals reports Q2 EPS (35c) vs. (26c) last year 05/16/22 scPharmaceuticals reiterates 2022 net loss $43M-$48M 05/16/22 scPharmaceuticals reports Q1 EPS (28c), consensus (31c) 03/22/22 scPharmaceuticals reports Q4 EPS (27c), consensus (34c) SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 03/22/22 Fly Intel: Pre-market Movers 10/08/22 PDUFA Date FUROSCIX (Furosemide)
Earnings	scPharmaceuticals reports Q2 EPS (35c) vs. (26c) last year » 07:03 08/09/22 08/09 07:03 08/09/22 07:03 SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) "The key highlight… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 07/12/22 scPharmaceuticals announces results from AT HOME-HF Phase 2 pilot study 06/30/22 scPharmaceuticals to host FUROSCIX commercial day 06/07/22 scPharmaceuticals announces abstracts accepted for AAHFN meeting 05/16/22 scPharmaceuticals announces FDA acceptance of FUROSCIX NDA SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 08/02/22 Maxim scPharmaceuticals initiated with a Buy at Maxim 09/09/21 SVB Leerink SVB Leerink starts scPharmaceuticals with a Market Perform, $6 target 09/09/21 SVB Leerink scPharmaceuticals initiated with a Market Perform at SVB Leerink SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 05/16/22 scPharmaceuticals reiterates 2022 net loss $43M-$48M 05/16/22 scPharmaceuticals reports Q1 EPS (28c), consensus (31c) 03/22/22 scPharmaceuticals reports Q4 EPS (27c), consensus (34c) SCPH scPharmaceuticals $5.36 / +0.185 (+3.57%) 03/22/22 Fly Intel: Pre-market Movers 10/08/22 PDUFA Date FUROSCIX (Furosemide)
Recommendations	FIS price target lowered to $160 from $176 at Susquehanna » 07:03 08/09/22 08/09 07:03 08/09/22 07:03 FIS FIS $98.15 / +0.73 (+0.75%) Susquehanna analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FIS FIS $98.15 / +0.73 (+0.75%) 07/11/22 RevoluGROUP signs addendum to agreement with FIS 06/07/22 FIS delivers derivatives solution to Societe Generale 05/16/22 Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet 05/11/22 FIS announces new embedded finance offering in partnership with Treasury Prime FIS FIS $98.15 / +0.73 (+0.75%) 08/08/22 Mizuho FIS price target lowered to $120 from $130 at Mizuho 08/05/22 Baird FIS price target lowered to $120 from $130 at Baird 08/04/22 Truist Marqeta weakness on FIS confusion a buying opportunity, says Truist 08/04/22 KeyBanc FIS win with Block not infringing on Marqeta relationship, says KeyBanc FIS FIS $98.15 / +0.73 (+0.75%) 08/04/22 FIS reports Q2 EPS $1.73, consensus $1.71 08/03/22 Notable companies reporting before tomorrow's open 08/03/22 Notable companies reporting before tomorrow's open 05/03/22 FIS sees FY22 EPS $7.25- $7.37, consensus $7.29 FIS FIS $98.15 / +0.73 (+0.75%) 08/04/22 Fly Intel: Pre-market Movers 06/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/03/22 Fly Intel: Pre-market Movers 02/15/22 What You Missed On Wall Street On Tuesday 08/10/22 5th Annual Insurance & Banking Technology Conference

Earnings	Eagle Pharmaceuticals reports Q2 non-GAAP EPS $1.78, consensus $3.36 » 07:02 08/09/22 08/09 07:02 08/09/22 07:02 EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 06/09/22 Eagle Pharmaceuticals complete acquisition of Acacia Pharma 06/01/22 Eagle Pharmaceuticals: AOP Orphan Pharma submits NDA to FDA for landiolol 04/19/22 Eagle announces settlement agreement with Hospira 03/28/22 Eagle Pharmaceuticals to acquire Acacia Pharma for EUR 0.90 per share EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 12/16/21 Barclays Endo price target lowered to $5 from $7 at Barclays 12/15/21 Cantor Fitzgerald Vasopressin approval 'a key win' for Eagle Pharmaceuticals, says Cantor 09/01/21 Piper Sandler Eagle Pharmaceuticals price target raised to $51 from $48 at Piper Sandler 08/31/21 Piper Sandler Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 05/09/22 Eagle Pharmaceuticals reports Q1 adjusted EPS $4.10, consensus $3.88 03/07/22 Eagle Pharmaceuticals sees Q1 adjusted EPS $3.80-$4.10, consensus $1.12 03/07/22 Eagle Pharmaceuticals reports Q4 adjusted EPS 85c, consensus 94c EGRX Eagle Pharmaceuticals $43.08 / -0.005 (-0.01%) 03/07/22 What You Missed On Wall Street On Monday 03/07/22 What You Missed On Wall Street This Morning 08:30 Today Eagle Pharmaceuticals - EGRX
Earnings	Anavex reports Q3 EPS (16c) vs. (14c) last year » 07:01 08/09/22 08/09 07:01 08/09/22 07:01 AVXL Anavex $11.45 / -0.205 (-1.76%) "We are pleased with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AVXL Anavex $11.45 / -0.205 (-1.76%) 08/02/22 Anavex announces long-lasting effects of ANAVEX 3-71 06/21/22 Anavex announces educational video news release 06/08/22 Anavex's publication supports clinical biomarker for ANAVEX 2-73 in Fragile X 04/27/22 Anavex announces presentations at IRSF Rett Syndrome Scientific Meeting AVXL Anavex $11.45 / -0.205 (-1.76%) 06/23/22 Berenberg Anavex initiated with a Buy at Berenberg 02/02/22 Cantor Fitzgerald Anavex price target lowered to $16 from $27 at Cantor Fitzgerald 11/26/21 Cantor Fitzgerald Anavex pipeline reads bode well for near-term value creation, says Cantor 09/23/21 BTIG Anavex initiated with a Buy at BTIG AVXL Anavex $11.45 / -0.205 (-1.76%) 05/10/22 Anavex reports Q1 EPS (14c), consensus (17c) 02/09/22 Anavex reports Q4 EPS (14c), consensus (15c) 16:30 Today Anavex - AVXL AVXL Anavex $11.45 / -0.205 (-1.76%) 07/20/22 Largest borrow rate increases among liquid names
Earnings	Hyatt sees FY22 comparable system-wide constant dollar RevPAR up 55%-60% » 07:01 08/09/22 08/09 07:01 08/09/22 07:01 H Hyatt $85.18 / +0.39 (+0.46%) For the 2022 fiscal year,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options H Hyatt $85.18 / +0.39 (+0.46%) 06/06/22 Hyatt reports May comparable system-wide RevPAR $127 06/02/22 Hyatt appoints Javier Aguila as group president, EAME 05/10/22 Hyatt sees FY22 CapEx view $210M 05/09/22 Hyatt unveils new Inclusive Collection luxury resort brands H Hyatt $85.18 / +0.39 (+0.46%) 07/11/22 Evercore ISI Hyatt assumed with an In Line at Evercore ISI 06/28/22 Barclays Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names 06/28/22 Barclays Hyatt initiated with an Overweight at Barclays 06/07/22 JPMorgan Hyatt has 'tremendous value' versus lodging c-corps, says JPMorgan H Hyatt $85.18 / +0.39 (+0.46%) 07:00 Today Hyatt reports Q2 adjusted EPS 46c, consensus 1c 08/08/22 Notable companies reporting before tomorrow's open 08/08/22 Notable companies reporting before tomorrow's open 05/10/22 Hyatt reports Q1 adjusted EPS (33c), consensus (36c) 23 Sep H Hyatt $85.18 / +0.39 (+0.46%) 02/16/22 Fly Intel: After-Hours Movers 09:00 Today Hyatt - H 09/20/22 Hyatt H Hyatt $85.18 / +0.39 (+0.46%) 04/06/22 Unusually active option classes on open April 6th
Downgrade	Trinseo downgraded to Hold from Buy at Fermium Research » 07:00 08/09/22 08/09 07:00 08/09/22 07:00 TSE Trinseo $35.19 / +0.43 (+1.24%) Fermium Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TSE Trinseo $35.19 / +0.43 (+1.24%) 07/26/22 Trinseo pauses sale of styrenics business 06/30/22 Trinseo, GMP announce intention to establish Netherlands recycling plant 04/27/22 Trinseo records estimated liability of $36M in styrene monomer E.U. activity 02/21/22 Trinseo appoints Andre Lanning as Chief Commercial Officer TSE Trinseo $35.19 / +0.43 (+1.24%) 07/27/22 Deutsche Bank Trinseo price target lowered to $42 from $52 at Deutsche Bank 07/14/22 Deutsche Bank Trinseo named short-term buy idea at Deutsche Bank 06/16/22 Jefferies Trinseo price target lowered to $54 from $70 at Jefferies 05/16/22 Deutsche Bank Trinseo price target lowered to $52 from $60 at Deutsche Bank TSE Trinseo $35.19 / +0.43 (+1.24%) 08/08/22 Trinseo sees FY22 adjusted EBITDA $475M-$525M 08/08/22 Trinseo reports Q2 adjusted EPS $1.79 vs $3.70 last year 05/04/22 Trinseo lowers FY22 adjusted EBITDA view $625M-$675M from $700M-$750M 05/04/22 Trinseo reports Q1 EPS $2.08, consensus $1.66 TSE Trinseo $35.19 / +0.43 (+1.24%) 08/08/22 Fly Intel: After-Hours Movers 10:00 Today Trinseo - TSE
Syndicate	ProKidney files to sell 232.5M shares of common stock for holders 07:00 08/09/22 08/09 07:00 08/09/22 07:00 PROK ProKidney $7.49 / -0.115 (-1.51%) ShowHide Related Items >><< Company News PROK ProKidney $7.49 / -0.115 (-1.51%) 07/20/22 ProKidney appoints Kerry Cooper as SVP, medical affairs 07/14/22 Social Capital Suvretta Holdings Crp III trading resumes 07/14/22 Social Capital Suvretta Holdings Crp III trading halted, volatility trading pause 07/12/22 ProKidney, Social Capital Suvretta complete business combination

Events

Earnings calls, analyst events, roadshows and more

BLDE
Today at 08:00

Blade Air Mobility - BLDE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
KPLT
Today at 08:00

Katapult - KPLT Conference Calls
KLTR
Today at 08:00

Kaltura - KLTR Conference Calls
AVDL
Today at 08:00

Avadel Pharmaceuticals - AVDL Conference Calls
SDC
Today at 08:00

SmileDirectClub - SDC Conference Calls
REYN
Today at 08:00

Reynolds Consumer Products - REYN Conference Calls
ACM
Today at 08:00

Aecom - ACM Conference Calls
CIFR
Today at 08:00

Cipher Mining - CIFR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

New Relic initiated with a Buy at Canaccord

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access